AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2024 · Annual

Operating Income

-$48.02M

FY 2024 · Annual

Net Income

-$46.27M

FY 2024 · Annual

Income Statement

EUR
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
Revenue000
Cost of Revenue000
Gross Profit000
Gross Margin———
Research & Development19.42M26.31M39.31M
Selling, General & Admin4.49M6M9.82M
Operating Expenses22.63M31.19M48.02M
Depreciation & Amortization23K99K311K
EBITDA(10.74M)(11.88M)(45.89M)
EBITDA Margin———
Operating Income(22.63M)(31.19M)(48.02M)
Operating Margin———
Interest Income71K245K1.22M
Interest Expense45K31K67K
Other Income / Expenses11.83M19.18M1.76M
Income Before Tax(10.81M)(12.01M)(46.26M)
Pre-Tax Margin———
Income Tax Expense(2.66M)(619K)4K
Net Income(8.14M)(11.39M)(46.27M)
Net Margin———
EPS (Basic)(0.22)(0.31)(1.26)
EPS (Diluted)(0.22)(0.31)(1.26)
Weighted Avg Shares36.24M36.24M36.24M
Weighted Avg Shares (Diluted)36.24M36.24M36.24M

AGMB Earnings Waterfall · TTM

NASDAQ:AGMB · Revenue to Net Income

No earnings data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 6, 2026
4Statement of changes in beneficial ownershipOct 22, 2026
6-K6-K filingOct 13, 2026
4Statement of changes in beneficial ownershipOct 9, 2026
4Statement of changes in beneficial ownershipOct 7, 2026

How much revenue does AGMB generate?

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) reported $0.00 of revenue in fiscal 2024.

Is AGMB profitable?

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) reported -$46.27M of net income.